🇺🇸 FDA
Patent

US 9187516

Compositions and methods for inhibiting expression of a gene from the Ebola virus

granted A61PA61P11/00A61P31/00

Quick answer

US patent 9187516 (Compositions and methods for inhibiting expression of a gene from the Ebola virus) held by The United States of America as represented by the Secretary of the Army expires Mon Nov 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of the Army
Grant date
Tue Nov 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61P, A61P11/00, A61P31/00, A61P31/14, A61P7/00